You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 18, October 27, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Staphylococcus aureus Endocarditis

Combined Therapy With Vancomycin and Rifampin

Ralph J. Faville, Jr, MD; Darwin E. Zaske, PharmD; Edward L. Kaplan, MD; Kent Crossley, MD; L. D. Sabath, MD; Paul G. Quie, MD

JAMA. 1978;240(18):1963-1965.


Abstract

Two children with persistent bacteremia and endocarditis due to Staphylococcus aureus failed to respond to vancomycin therapy, even though serum levels greatly exceeded the inhibitory concentrations. The Staphylococcus from one patient was resistant to methicillin; the other patient had a penicillin hypersensitivity. There was a wide disparity between the minimum inhibitory and the minimum bactericidal concentrations of vancomycin. Striking clinical and laboratory evidence of improvement was demonstrated with the addition of rifampin therapy.

(JAMA 240:1963-1965, 1978)



Author Affiliations

From the Departments of Pediatrics (Drs Faville, Kaplan, and Quie), Medicine (Drs Crossley and Sabath), and Microbiology (Dr Quie), and the Division of Clinical Pharmacy (Dr Zaske), University of Minnesota Hospitals, and the Departments of Pediatrics (Dr Faville) and Medicine (Dr Crossley), and the Division of Clinical Pharmacy (Dr Zaske), St Paul-Ramsey Hospital, St Paul.


Footnotes

Read in part before the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Oct 28, 1976.

Reprint requests to Department of Pediatrics, St Paul-Ramsey Hospital, 640 Jackson St, St Paul, MN 55101 (Dr Faville).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused by Staphylococcus aureus
Riedel et al.
Antimicrob. Agents Chemother. 2008;52:2463-2467.
ABSTRACT | FULL TEXT  

Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French
J Antimicrob Chemother 2006;58:1107-1117.
ABSTRACT | FULL TEXT  

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Sakoulas et al.
J. Clin. Microbiol. 2004;42:2398-2402.
ABSTRACT | FULL TEXT  

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
Wilcox et al.
J Antimicrob Chemother 2004;53:335-344.
ABSTRACT | FULL TEXT  

Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus
Vaudaux et al.
J Antimicrob Chemother 2003;52:89-95.
ABSTRACT | FULL TEXT  

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcusaureus
Sakoulas et al.
Antimicrob. Agents Chemother. 2003;47:1714-1718.
ABSTRACT | FULL TEXT  

Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus
Vaudaux et al.
Antimicrob. Agents Chemother. 2002;46:1503-1509.
ABSTRACT | FULL TEXT  

Antibiotic Therapy for Musculoskeletal Infections
Mader et al.
JBJS 2001;83:1878-1890.
FULL TEXT  

Amoxycillin tolerance in Helicobacter pylori
Dore et al.
J Antimicrob Chemother 1999;43:47-54.
ABSTRACT | FULL TEXT  

Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis
Levine et al.
ANN INTERN MED 1991;115:674-680.
ABSTRACT  

Staphylococcal CNS Infections Treated With Vancomycin and Rifampin
Vichyanond and Olson
Arch Neurol 1984;41:637-639.
ABSTRACT  

Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with Granulocytopenia
WADE et al.
ANN INTERN MED 1982;97:503-508.
ABSTRACT  

Community-Acquired Methicillin-Resistant Staphylococcus aureus Endocarditis in the Detroit Medical Center
LEVINE et al.
ANN INTERN MED 1982;97:330-338.
ABSTRACT  

Mechanisms of Resistance to Beta-lactam Antibiotics in Strains of Staphylococcus aureus
SABATH
ANN INTERN MED 1982;97:339-344.
ABSTRACT  

Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus
SORRELL et al.
ANN INTERN MED 1982;97:344-350.
ABSTRACT  

Staphylococcal Bacteremia and Endocarditis: State of the Art
Bayer
Arch Intern Med 1982;142:1169-1177.
ABSTRACT  

Surgery in Active Endocarditis
DINUBILE
ANN INTERN MED 1982;96:650-659.
ABSTRACT  

Bacterial Endocarditis with a Tolerant Staphylococcal Organism
McMillan and Weiner
CLIN PEDIATR 1982;21:252-254.
ABSTRACT  

Tolerant Staphylococcus aureus Causing Vertebral Osteomyelitis
Musher and Fletcher
Arch Intern Med 1982;142:632-634.
ABSTRACT  

Trimethoprim-Sulfamethoxazole Treatment of Multiantibiotic-Resistant Staphylococcal Endocarditis and Meningitis
Tamer and Bray
CLIN PEDIATR 1982;21:125-126.
ABSTRACT  

Nafcillin-Tolerant Staphylococcus epidermidis Endocarditis
Arthur et al.
JAMA 1982;247:487-488.
ABSTRACT  

The Clinical Significance of Tolerance of Staphylococcus aureus
KAYE
ANN INTERN MED 1980;93:924-926.
ABSTRACT  

Combination Antibiotic Therapy of Bacterial Endocarditis
SANDE and SCHELD
ANN INTERN MED 1980;92:390-395.
ABSTRACT  

Staphylococci and Combination Therapy
Andriole
Arch Intern Med 1979;139:1090-1091.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.